Reviva Pharmaceuticals Holdings, Inc. (RVPH) stock
RVPHOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 2/30
$0.45−0.02 (-4.36%)
Close on Oct 19, 2026Market cap $5.94MP/E –Yield –
Reviva Pharmaceuticals operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Reviva Pharmaceuticals's operating cash flow for the twelve months ending Sep 30, 2026 was -$13.90M. For fiscal 2025 it was -$24.59M. The highest annual figure on record is -$218.44K in fiscal 2019.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$24.59M | – |
| FY2024 | Dec 31, 2024 | -$33.54M | – |
| FY2023 | Dec 31, 2023 | -$28.32M | – |
| FY2022 | Dec 31, 2022 | -$18.96M | – |
| FY2021 | Dec 31, 2021 | -$10.67M | – |
| FY2020 | Dec 31, 2020 | -$4.07M | – |
| FY2019 | Dec 31, 2019 | -$218.44K | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$2.18M | – |
| Q2 FY2026 | Jun 30, 2026 | -$2.12M | – |
| Q1 FY2026 | Mar 31, 2026 | -$3.80M | – |
| Q4 FY2025 | Dec 31, 2025 | -$5.80M | – |
| Q3 FY2025 | Sep 30, 2025 | -$5.59M | – |
| Q2 FY2025 | Jun 30, 2025 | -$5.01M | – |
| Q1 FY2025 | Mar 31, 2025 | -$8.19M | – |
| Q4 FY2024 | Dec 31, 2024 | -$9.10M | – |
| Q3 FY2024 | Sep 30, 2024 | -$4.24M | – |
| Q2 FY2024 | Jun 30, 2024 | -$8.48M | – |
| Q1 FY2024 | Mar 31, 2024 | -$11.73M | – |
| Q4 FY2023 | Dec 31, 2023 | -$8.88M | – |
| Q3 FY2023 | Sep 30, 2023 | -$6.18M | – |
| Q2 FY2023 | Jun 30, 2023 | -$5.32M | – |
| Q1 FY2023 | Mar 31, 2023 | -$7.95M | – |
| Q4 FY2022 | Dec 31, 2022 | -$4.69M | – |
| Q3 FY2022 | Sep 30, 2022 | -$4.00M | – |
| Q2 FY2022 | Jun 30, 2022 | -$4.00M | – |
| Q1 FY2022 | Mar 31, 2022 | -$6.27M | – |
| Q4 FY2021 | Dec 31, 2021 | -$3.90M | – |
| Q3 FY2021 | Sep 30, 2021 | -$2.31M | – |
| Q2 FY2021 | Jun 30, 2021 | -$1.34M | – |
| Q1 FY2021 | Mar 31, 2021 | -$3.12M | – |
| Q2 FY2018 | Aug 31, 2018 | -$92.35K | – |
See a number that looks wrong?